Hepatobiliary Neoplasm

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-03-29
Clinical Trial Update: Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors [Phase 2]
Phase 2 trial evaluating axitinib plus toripalimab as second-line therapy for hepatobiliary neoplasms and liver neoplasms.